Search the Newsreel

T. Rowe Price (CECO) discloses 2.15M CECO Environmental shares, 3.7% stake

T. Rowe Price Investment Management, Inc. has filed an amended Schedule 13G, disclosing a 3.7% stake in CECO Environmental Corp, totaling 2,153,953 shares. The firm reports sole voting power over 2,147,618 shares and sole dispositive power over 2,153,953 shares. T. Rowe Price denies that …

Armistice Capital (ICCM) reports 300,332 IceCure Medical shares under shared control

Armistice Capital, LLC and Steven Boyd have reported beneficial ownership of 300,332 ordinary shares of IceCure Medical Ltd. (ICCM), representing 9.99% of the class, through a Schedule 13G SEC filing. These shares are held with shared voting and dispositive power. Armistice Capital acts as …

CECO Environmental (CECO): American Century group reports 3.6% ownership stake

American Century Investment Management, Inc., American Century Companies, Inc., and the Stowers Institute for Medical Research have collectively reported a passive ownership stake of 3.6% in CECO Environmental Corp., as detailed in a Schedule 13G/A filing. This group beneficially owns 2,088,421 shares, with sole …

FY2026 EPS Estimates for CECO Lifted by Northland Securities

Northland Securities has increased its FY2026 EPS forecast for CECO Environmental (NASDAQ:CECO) to $2.24 per share, up from $1.96, exceeding the consensus estimate of $2.12. This follows CECO's recent strong quarterly performance, where it reported $0.47 EPS against an analyst consensus of $0.26 and …

IceCure Medical (Nasdaq: ICCM) updates filing for 533,334 warrant-share resales

IceCure Medical Ltd. has filed a post-effective amendment to its Form F-1 to update financial information and maintain the effectiveness of a resale registration. This filing concerns the potential resale of up to 533,334 Ordinary Shares by existing selling shareholders, which are issuable upon …

IceCure Medical (ICCM) details 324,802-share warrant issuance and $9.7M potential proceeds

IceCure Medical Ltd. has filed a post-effective amendment to register the issuance of up to 324,802 Ordinary Shares upon the exercise of outstanding warrants from a previous rights offering. The exercise includes warrants at $30.00 per share and pre-funded warrants at $0.003 per share, …

IceCure Highlights Two New Peer-Reviewed Publications Supporting Cryoablation in Breast Cancer Treatment De-Escalation

IceCure Medical announced two new peer-reviewed publications that support the increasing role of cryoablation in breast cancer treatment de-escalation. One review highlights ProSense®'s FDA authorization, ASBrS guidelines, and positive ICE3 trial outcomes, while the second expands cryoablation's use to axillary lymph node metastases for …

CECO Environmental (NASDAQ:CECO) Downgraded to "Hold" Rating by Zacks Research

Zacks Research downgraded CECO Environmental (NASDAQ:CECO) from "strong buy" to "hold," despite the broader analyst consensus remaining a "Moderate Buy" with an average price target of $104. The company recently reported strong quarterly earnings, exceeding analyst expectations with $0.47 per share and $284.96 million …

IceCure Medical Q2 2026 Earnings Call Transcript

IceCure Medical reported a 45% year-over-year revenue increase to $1.8 million for the first half of 2026, driven by higher ProSense system sales and disposable probe utilization. The company's U.S. commercial install base grew by 70% to over 30 sites following FDA clearance for …

IceCure Medical Ltd Q2 2026 Earnings Call Summary

IceCure Medical Ltd Q2 2026 Earnings Call Summary - Moby Strategic Performance and Operational Context Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap …

Earnings call transcript: IceCure Medical misses Q2 2026 estimates as shares fall

IceCure Medical reported a 45% year-over-year revenue increase to $1.8 million for the first half of 2026, driven by higher ProSense system sales and disposable probe utilization. The company's U.S. commercial install base grew by 70% to over 30 sites following FDA clearance for …

IceCure Medical (Nasdaq: ICCM) lifts H1 revenue 45% but burns cash

IceCure Medical Ltd. (ICCM) reported a 45% increase in H1 2026 revenue to $1.818 million, driven by higher system and disposable probe sales. Despite this growth, the company experienced a deepened net loss of $8.775 million and negative operating cash flow, leading management to …

ICECURE MEDICAL ($ICCM) Releases Q2 2026 Earnings

IceCure First-Half 2026 Earnings: 45% Revenue Growth Comes With Wider Losses

IceCure Reports its Financial Results for the First Half of 2026 with 45% Revenue Growth Year-Over-Year

IceCure Medical Ltd. announced strong financial results for the first half of 2026, reporting a 45% year-over-year revenue growth to $1.8 million, driven by increased sales of its ProSense® systems and disposable probes. The company expanded its U.S. commercial footprint by 70% and ended …

IceCure's Active U.S. Install Base Grows About 70%; Cash $12M

CECO Environmental (CECO) Stock Rallies On Record Revenue And Margin Gains

IceCure Medical (ICCM) names David Salton to board as independent director

IceCure Medical Ltd. (ICCM) has appointed David Salton as an independent Class II director to its Board, effective until the 2027 annual general meeting. This appointment follows the resignation of Vincent Chun Hung Chan, which the company stated was not due to any disagreements. …

How Investors Are Reacting To CECO Environmental (CECO) Record Q2 Sales And Raised 2026 Revenue Outlook

CECO Environmental Corp (CECO) (Q2 2026) Earnings Call Highlights: Record Orders and Backlog ...

CECO Environmental Corp reported record Q2 2026 orders of $799 million, up 191% year-over-year, and a backlog of $1.8 billion. Revenue increased 54% to $285 million, with adjusted EBITDA up 73% to $40.2 million and an expanded margin of 14.1%. The company raised its …

CECO Environmental (CECO) Q2 Earnings Report Preview: What To Look For

CECO Environmental Releases Q2 2026 Financial Results

CECO Environmental Corp. announced strong Q2 2026 financial results, with non-GAAP earnings of $0.47 per share, significantly beating analysts' forecasts. The company reported revenue of $285.0M, a 54% increase year-over-year, and provided full-year revenue guidance between $1.30B and $1.38B, reflecting confidence in continued growth. …

CECO Environmental (NASDAQ: CECO) grows revenue but posts Q2 2026 loss after $2.26B Thermon buy

What CECO Environmental (CECO)'s Strong Revenue Growth and Net Loss Widening Means For Shareholders

CECO Environmental Delivers Strong Q2 2026 Earnings Beat, Revenue Up 54%

Earnings call transcript: CECO Environmental posts record Q2 2026 results, raises outlook

CECO Environmental Posts Record Q2, Raises 2026 Outlook on Surging Orders and Thermon Deal

CECO Environmental reported record Q2 2026 results with orders surging 191% to $799 million and revenue climbing 54% to $285 million, significantly exceeding expectations. The strong performance was driven by the integration of the Thermon acquisition, which is already delivering $13 million in annualized …

CECO Environmental shares jump 8% after Q2 beat and guidance increase

Blue chart going up ©Adobe Stock Images CECO Environmental Corp. (NASDAQ:CECO) shares surged 8.57% in pre-market trading on Monday after the environmental technology company delivered second-quarter results that comfortably exceeded Wall Street expectations and raised its full-year outlook. Adjusted earnings per share reached $0.47, …

CECO Environmental Corp. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:CECO) 2026-08-10

This article provides the earnings call presentation from CECO Environmental Corp. for their Q2 2026 results. The company reported an EPS of $0.47, beating estimates by $0.14, and revenue of $284.96 million, a 53.71% year-over-year increase, beating estimates by $2.75 million. The presentation was …

Is CECO Environmental Corp (CECO) Overvalued After Q2 Earnings?

CECO Environmental Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

Record-Setting Second Quarter Highlighted by Strong Orders, Up 191 Percent and Backlog Above $1.8 Billion Thermon Integration Delivering Synergies Ahead of Plan Company Raises Full Year Consolidated 2026 Outlook ADDISON, Texas, Aug. 10, 2026 (GLOBE NEWSWIRE) -- CECO Environmental Corp. (Nasdaq: CECO) ("CECO"), a …

CECO Environmental stock surges 8% on Q2 beat, raised guidance

CECO Environmental Corp. (NASDAQ:CECO) reported a strong second quarter, surpassing analyst expectations for both adjusted EPS and revenue. The company also raised its full-year 2026 revenue and adjusted EBITDA guidance, following significant growth in orders and backlog. This positive performance led to an 8% …

Earnings Flash (CECO) CECO Environmental Corp. Posts Q2 Adjusted EPS $0.47 per Share, vs. FactSet Est of $0.26